Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen.
D000328:Adult; D000888:Antibodies, Anti-Idiotypic; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001798:Blood Proteins; D003168:Complement Fixation Tests; D005260:Female; D016027:Heart Transplantation; D006509:Hepatitis B / Q000097:blood / Q000209:etiology*; D006801:Humans; D006942:Hypergammaglobulinemia / Q000209:etiology; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008099:Liver / Q000503:physiopathology; D008107:Liver Diseases / Q000209:etiology*; D008111:Liver Function Tests; D016031:Liver Transplantation; D011183:Postoperative Complications; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012709:Serum Albumin; D014184:Transplantation, Homologous
D000888:Antibodies, Anti-Idiotypic; D001798:Blood Proteins; D012709:Serum Albumin; D011239:Prednisolone; D001219:Aspartate Aminotransferases; D001379:Azathioprine; D001663:Bilirubin; D011241:Prednisone